Clinical Trial Update: A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bortezomib for pulmonary chronic GVHD in bronchiolitis obliterans was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Northwestern University | Conditions: Bronchiolitis Obliterans | Phase 2 | Status: TERMINATED | Results posted: 2020-04-10